VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Journal:

Journal of Clinical Oncology

Published:

2026-03-10

DOI:

10.1200/jco-25-02643

Affiliations:

26

Authors:

159

Go to article

Institutions	Authors	Share
Celcuity Inc., United States of America (USA)	5.000000	0.19
Institute Gustave-Roussy (IGR), France	2.000000	0.08
Weill Cornell Medicine, United States of America (USA)	1.000000	0.04
Centre François Baclesse, France	1.000000	0.04
Breast Cancer Research Centre-WA, Australia	1.000000	0.04
Asan Medical Center (AMC), South Korea	1.000000	0.04
Filios Alta Medicina, Mexico	1.000000	0.04
Centro de Enfermedades Reumatológicas San Juan (CER San Juan), Argentina	1.000000	0.04
Harvard Dana-Farber/Harvard Cancer Center (DF/HCC), United States of America (USA)	1.000000	0.04
British Hospital, Argentina	1.000000	0.04
Centro Médico Fleischer, Argentina	1.000000	0.04
National Institute of Medical Science and Nutrition Salvador Zubiran (INCMNSZ), Mexico	1.000000	0.04
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	1.000000	0.04
Instituto Alexander Fleming, Argentina	1.000000	0.04
Yonsei Cancer Hospital, South Korea	1.000000	0.04
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)	1.000000	0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.04
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	1.000000	0.04
IRCCS European Institute of Oncology (IEO), Italy	0.500000	0.02
University of Milan (UNIMI), Italy	0.500000	0.02
Fred Hutchinson Cancer Center, United States of America (USA)	0.500000	0.02
University of Washington (UW), United States of America (USA)	0.500000	0.02
Spanish Research Group on Breast Cancer (GEICAM), Spain	0.333333	0.01
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain	0.333333	0.01
Gregorio Marañon University Hospital, Spain	0.333333	0.01

Interested in Oncology and Carcinogenesis?